G1T28
We provide customized and high-quality Trilaciclib product for your project.
Trilaciclib is a CDK4/6 inhibitor with IC50 of 1 nM and 4 nM, respectively. It is developed to reduce the burden of chemotherapy-induced myelosuppression in patients with small cell lung cancer.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View